ALNYLAM PHARMACEUTICALS, INC. Payments to Acquire Interest in Joint Venture
ALNYLAM PHARMACEUTICALS, INC. (ALNY) reported Payments to Acquire Interest in Joint Venture of $10.00 million for the 12-month period ending 2009-12-31, per its 10-K filed 2012-02-13.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInterestInJointVenture · last filed 2012-02-13
- ALNYLAM PHARMACEUTICALS, INC. payments to acquire interest in joint venture for the quarter ending 2009-12-31 was $0.00.
- ALNYLAM PHARMACEUTICALS, INC. payments to acquire interest in joint venture for the quarter ending 2009-09-30 was $0.00.
- ALNYLAM PHARMACEUTICALS, INC. payments to acquire interest in joint venture for fiscal 2009 was $10.00M, a 9900.00% increase from fiscal 2008.
- ALNYLAM PHARMACEUTICALS, INC. payments to acquire interest in joint venture for fiscal 2008 was $100.00K.
| Period end | Payments to Acquire Interest in Joint Venture 3 month | Payments to Acquire Interest in Joint Venture 6 month | Payments to Acquire Interest in Joint Venture 9 month | Payments to Acquire Interest in Joint Venture 12 month |
|---|---|---|---|---|
| 2009-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-13 | $0.00 derived: sum of 2 quarters · filed 2012-02-13 | $10.00M 10-K · filed 2012-02-13 | |
| 2009-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-04 | $10.00M 10-Q · filed 2010-11-04 | ||
| 2009-06-30 | $10.00M 10-Q · filed 2010-08-05 | |||
| 2008-12-31 | $100.00K 10-K · filed 2011-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |